Company: RILYN
Filing Date: 2025-02-21
Form Type: 10-Q
Source: 0001628280-25-007082
Chunk: 10

Company: B. Riley Financial, Inc.
Filing Date: 2025-02-21
Form: 10-Q
Item: Part I, Item 1
Chunk 10
---
 cash sold and other258 17,346 Purchases of property, equipment and intangible assets(6,725)(5,782)Funds received from trust account of subsidiary— 175,763 Purchase of equity and other investments(1,065)(4,871)Net cash provided by investing activities25,529 312,954 Cash flows from financing activities:  Proceeds from revolving line of credit64,101 191,265 Repayment of revolving line of credit(94,221)(261,697)Proceeds from note payable15,000 — Repayment of notes payable and other(6,156)(11,853)Repayment of term loan(138,574)(504,246)Proceeds from term loan— 628,187 Proceeds from issuance of senior notes— 185 Redemption of senior notes(140,491)(58,924)Payment of debt issuance and offering costs(3,484)(27,188)Payment of contingent consideration(7,395)(1,884)ESPP and payment of employment taxes on vesting of restricted stock(3,136)(8,619)Common dividends paid(33,627)(110,959)Preferred dividends paid(6,045)(6,042)Repurchase of common stock— (53,688)Distribution to noncontrolling interests(4,560)(4,012)Contributions from noncontrolling interests3,213 4,312 Redemption of subsidiary temporary equity and distributions— (175,763)Proceeds from issuance of common stock— 115,000 Proceeds from issuance of preferred stock— 467 Proceeds from exercise of warrants653 — Net cash used in financing activities(354,722)(285,459)Decrease in cash, cash equivalents and restricted cash(62,899)(13,462)Effect of foreign currency on cash, cash equivalents and restricted cash(1,092)(3,116)Net decrease in cash, cash equivalents and restricted cash(63,991)(16,578)Cash, cash equivalents and restricted cash from continuing operations, beginning of period224,565 225,981 Cash, cash equivalents and restricted cash from discontinued operations, beginning of period9,274 44,945 Cash, cash equivalents and restricted cash, beginning of year233,839 270,926 Cash, cash equivalents and restricted cash from continuing operations, end of period160,613 226,431